Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 54, n. 4, p. e17349, 2018. DOI: 10.1590/s2175-97902018000417349. Disponível em: https://revistas.usp.br/bjps/article/view/159278.. Acesso em: 4 may. 2024.